This "end-users" meeting tackles the challenges of integrating RNAi technology into your functional genomics and target validation studies. If you are using RNAi as a research tool, this is one meeting you can't afford to miss!

SPEAKERS FROM:
Abbott | Boehringer Ingelheim | Cenix | Cornell | Eli Lilly | Exelixis | GNF | Harvard | Hoffmann-La Roche | Max Planck | Merck | NIST | Novartis | Pfizer | Tufts | Whitehead 
Wyeth

CONFERENCE FEATURES:

• Pre-Conference Tutorial: More Effective RNAi Studies with
  High-Content Screening
• Post-Conference RNAi End-User Forum (open to end-users only)
• 2006 Highlight: Integrating siRNA and Compound Library Screening
• Expanded Coverage of High-Content Screening of siRNA
•  Case Studies of Genome-Wide siRNA Screening, Pathway Analysis, and Target Validation
• Technology Showcase Highlighting Latest Tools
• Optional Access to Co-Located High-Content Analysis Sessions, Exhibits, and User Group Meetings

New This Year!
CO-LOCATED Third Annual High-Content Analysis conference
The most comprehensive and focused coverage of high-content cellular assays applications and technologies, including a 4-day scientific program, comprehensive trade show, technology showcases, and co-located user group meetings hosted by leading technology providers. 
Visit www.highcontentanalysis.com for complete details.

DISTINGUISHED FACULTY:

• Dr. John Blenis, Professor of Cell Biology, Harvard Medical School
• Dr. Anne E. Carpenter, Novartis Fellow of the Life Sciences Research Foundation, Sabatini Laboratory, Whitehead Institute for Biomedical Research
• Dr. Namjin Chung, Senior Research Scientist, Automated Biotechnology, Merck Research Laboratories
• Dr. Robert Dullea, Principal Scientist, Genetic Technologies, Pfizer Inc.
• Dr. Christophe J. Echeverri, CEO/CSO, Cenix BioScience GmbH 
• Dr. John Elliott, Research Scientist, Biotechnology, National Institute of Standards and Technology (NIST)
• Dr. Yan Feng, Lab Head, Genome and Proteome Sciences, Novartis Institute for BioMedical Research
• Mr. Ross Francis, Senior Scientist, Target Discovery, Exelixis, Inc.
• Dr. Steven Haney, Senior Scientist, Biological Technologies, Wyeth Research
• Dr. Eberhard Krausz, HT-Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG)
• Dr. Siu Sylvia Lee, Assistant Professor, Department of Molecular Biology and Genetics, Cornell University
• Dr. Daniel R. Rines, Institute Fellow, Lead Discovery, Genomics Institute of the Novartis Research Foundation (GNF)
• Dr. Jörg F. Rippmann, Head, Genomics Group, Boehringer Ingelheim Pharma GbmB & Co. KG
• Dr. Cristina M. Rondinone, Director of Research, Metabolic Diseases, Hoffmann-La Roche Inc. 
• Dr. Yu Shen, Group Leader, Cancer Exploratory Biology, Abbott Laboratories
• Dr. Orian Shirihai, Professor, Pharmacology, Tufts University Medical School
• Dr. Louis Stancato, Principal Research Scientist, Cancer Growth and Translational Genetics, Eli Lilly and Company
• Mr. Joseph A. Zock, Senior Manager, HCS User Services, Cellomics, Inc.

For more information please contact: 
Julia Boguslavsky, Conference Director, Cambridge Healthtech Institute
Phone: 781-972-5482 or E-mail: juliab@healthtech.com

For exhibit and sponsorship information, please contact:
Carol Dinerstein, Manager, Business Development
Phone: 781-972-5471 • E-mail: dinerstein@healthtech.com